SGL-H-S (BRS-01) is a long-acting GLP-1 receptor agonist used in qualified labs to study incretin signaling, appetite pathways, gastric emptying, insulin secretion, and energy-balance biology in controlled models. Publications describe its acylated design for albumin binding and weekly-dosing pharmacology, receptor selectivity, and common study paradigms in metabolic research.
All products are intended for in vitro, or laboratory research use only. This compound is not intended for therapeutic or diagnostic purposes and has not been approved by the FDA for human or veterinary use.
** This product is in lyophilized powder form and requires reconstitution solution (BAC Water) for research.
Additional Resources: